Literature DB >> 41173

Squalene synthetase.

G Popják, W S Agnew.   

Abstract

In the first part of the review the background to the discovery of the asymmetric synthesis of squalene from two molecules of farnesyl pyrophosphate and NADPH is described, then the stereochemistry of the overall reaction is summarized. The complexity of the biosynthesis of squalene by microsomal squalene synthetase demanded the existence of some intermediate(s) between farnesyl pyrophosphate and squalene. This demand was satisfied by the discovery of presqualene pyrophosphate, an optically active C30 substituted cyclopropylcarbinyl pyrophosphate, the absolute configuration of which at all three asymmetric centers of the cyclopropane ring was deduced to be R. Possible mechanisms for the biosynthesis of presqualene pyrophosphate and its reductive transformation into squalene are presented. In the second part of the review the nature of the enzyme is discussed. The question whether presqualene pyrophosphate is an obligate intermediate in the biosynthesis of squalene is examined, with the firm conclusion that it is. It is as yet uncertain whether the two half reactions of squalene synthesis, i.e. (i) 2 x farnesyl pyrophosphate leads to presqualene pyrophosphate; (ii) presqualene pyrophosphate + NADPH (NADH) leads to squalene, are catalyzed by one or two enzymes or by a large complex with two catalytic sites. Evidence is cited for the existence on the enzyme of two distinct binding sites with different affinities for the two farnesyl pyrophosphate molecules. The types of enzyme preparations available at present are described and types of experiments carried out with these are critically examined. The implications of the properties of a low molecular weight squalene synthetase solubilized with deoxycholate from microsomal membranes is discussed and a model for the enzyme in an organized membrane structure is presented.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41173     DOI: 10.1007/bf00218354

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  55 in total

1.  Stereospecific insertion of hydrogen atom into squalene from reduced nicotinamide-adenine dinucleotides.

Authors:  J W CORNFORTH; R H CORNFORTH; C DONNINGER; G POPJAK; G RYBACK; G J SCHROEPFER
Journal:  Biochem Biophys Res Commun       Date:  1963-04-23       Impact factor: 3.575

2.  Stereochemistry of enzymic hydrogen transfer to pyridine nucleotides.

Authors:  J W CORNFORTH; G RYBACK
Journal:  Biochem Biophys Res Commun       Date:  1962-11-27       Impact factor: 3.575

3.  Studies on the biosynthesis of cholesterol. XII. Synthesis of allyl pyrophosphates from mevalonate and their conversion into squalene with liver enzymes.

Authors:  D S GOODMAN; G POPJAK
Journal:  J Lipid Res       Date:  1960-07       Impact factor: 5.922

4.  Studies on the biosynthesis of cholesterol. XV. Mechanism of squalene biosynthesis from farnesyl pyrophosphate and from mevalonate.

Authors:  G POPJAK; W S GOODMAN; J W CORNFORTH; R H CORNFORTH; R RYHAGE
Journal:  J Biol Chem       Date:  1961-07       Impact factor: 5.157

5.  On the mechanism of squaiene biogenesis from mevalonic acid.

Authors:  H C RILLING; K BLOCH
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

6.  Studies on the biosynthesis of cholesterol. 5. Biosynthesis of squalene from DL-3-hydroxy-3-methyl [2-14C] pentano-5-lactone.

Authors:  J W CORNFORTH; R H CORNFORTH; G POPJAK; I Y GORE
Journal:  Biochem J       Date:  1958-05       Impact factor: 3.857

7.  Studies on the biosynthesis of cholesterol. VI. Companions of cholesterol-C14 in liver perfusions, including squalene-C14 as possible precursors in its biosynthesis.

Authors:  E SCHWENK; D TODD; C A FISH
Journal:  Arch Biochem Biophys       Date:  1954-03       Impact factor: 4.013

8.  Presqualene alcohol. Further evidence on the structure of a C 30 precursor of squalene.

Authors:  J Edmond; G Popják; S M Wong; V P Williams
Journal:  J Biol Chem       Date:  1971-10-25       Impact factor: 5.157

9.  Enzymic conversion of farnesyl pyrophosphate to squalene.

Authors:  G Krishna; H W Whitlock; D H Feldbruegge; J W Porter
Journal:  Arch Biochem Biophys       Date:  1966-04       Impact factor: 4.013

10.  Synthesis and conversion of presqualene alcohol to squalene.

Authors:  L J Altman; R C Kowerski; H C Rilling
Journal:  J Am Chem Soc       Date:  1971-04-07       Impact factor: 15.419

View more
  6 in total

1.  Screening for differentially expressed genes in endophytic fungus strain 39 during co-culture with herbal extract of its host Dioscorea nipponica Makino.

Authors:  Chang-Hong Ding; Xiao-Wei Du; Ying Xu; Xiao-Meng Xu; Jin-Chao Mou; Dan Yu; Jun-Kai Wu; Fan-Jia Meng; Yan Liu; Wan-Li Wang; Li-Juan Wang
Journal:  Curr Microbiol       Date:  2014-06-04       Impact factor: 2.188

2.  Molecular cloning and characterization of the yeast gene for squalene synthetase.

Authors:  S M Jennings; Y H Tsay; T M Fisch; G W Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

3.  YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species.

Authors:  T Ugawa; H Kakuta; H Moritani; K Matsuda; T Ishihara; M Yamaguchi; S Naganuma; Y Iizumi; H Shikama
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Conservation between human and fungal squalene synthetases: similarities in structure, function, and regulation.

Authors:  G W Robinson; Y H Tsay; B K Kienzle; C A Smith-Monroy; R W Bishop
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

5.  Quantitative determination of geranyl diphosphate levels in cultured human cells.

Authors:  Sarah A Holstein; Huaxiang Tong; Craig H Kuder; Raymond J Hohl
Journal:  Lipids       Date:  2009-10-24       Impact factor: 1.880

6.  Regulation of squalene synthase, a key enzyme of sterol biosynthesis, in tobacco.

Authors:  Timothy P Devarenne; Anirban Ghosh; Joe Chappell
Journal:  Plant Physiol       Date:  2002-07       Impact factor: 8.340

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.